Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Senate Health and Welfare trims pharmacy compounding labeling language after weeks of stakeholder concern
Summary
The committee approved the Idaho State Board of Pharmacypending rule chapter but voted to strike two subsections of a labeling provision after testimony highlighted unsettled federal guidance and industry concern about access to compounded products.
The Idaho Senate Health and Welfare Committee voted to approve the Idaho State Board of Pharmacypending rule chapter (docket 24-3601-2402) but removed two subsections of a distribution/labeling provision after senators raised concerns about how federal draft guidance could affect access and liability for compounded products.
The decision came after a detailed presentation by Nikki Chopsky, bureau chief for health professions at the Division of Occupational and Professional Licenses and executive officer for the Idaho State Board of Pharmacy. Chopsky told the committee the board reviewed more than 35 changes to the pharmacy rule chapter as part of a Zero-Based Regulation rewrite and that stakeholders — including representatives from both state pharmacy associations, industry groups and manufacturers — had multiple opportunities to comment.
Chopsky said the board moved several items from rule into statute following 2024 legislation, simplified duplicative…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
